Riskpilot← Back to searchSign inGet full accessArs Clinica Konsult AB
ABActiveOrg 5591626188Föreningsgatan 33Hospital activities · NACE 8610Est. 20180 employees
Revenue 2025
SEK 0
EBITDA margin
—
-109% vs 2024
Equity ratio
81.4%
Financial strength
Net profit 2025
SEK -27K
-108% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -34K | -109% |
| Net profit | SEK -27K | -108% |
| Total assets | SEK 2,5M | +7% |
| Equity | SEK 2M | -8% |
| Employees | 0 | — |
Legal name
Ars Clinica Konsult AB
Org number
5591626188
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
18 juni 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Läkarbemanning och konsult inom kirurgi och medicin.
Address
Föreningsgatan 33
Email
arsclinica2018@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 531 | 0 | 54 | 425 | 0 |
| Staff expenses | — | — | — | −0 | — |
| EBITDA | 515 | −36 | 27 | 386 | −34 |
| Depreciation & amort. | −0 | −0 | −0 | — | −0 |
| EBIT | 515 | −36 | 27 | 386 | −34 |
| Net financials | — | −2 | — | 51 | 7 |
| Profit before tax | 515 | −38 | 27 | 438 | −27 |
| Tax | −110 | −0 | −5 | −93 | −0 |
| Net profit | 405 | −38 | 22 | 345 | −27 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 007 | 1 833 | 1 851 | 2 301 | 2 463 |
| Equity | 1 853 | 1 815 | 1 837 | 2 182 | 2 005 |
| Long-term debt | 0 | 0 | 0 | — | 444 |
| Short-term debt | 154 | 18 | 15 | 119 | 14 |
| Total debt | 154 | 18 | 15 | 119 | 458 |
EBITDA margin
-3400000.0%
This company
15.8%
Market median
-21519087% vs market
20212025
Equity ratio
81.4%
This company
38.2%
Market median
+113% vs market
20212025
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20212025
Net profit margin
-2700000.0%
This company
8.1%
Market median
-33333433% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ars Clinica Konsult AB 
Ars Chirurgica Konsult ABBoard members of Ars Clinica Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Angelo Termini | Chief Executive Officer | 0 companies |
| Ulf Gregor Ryder | Deputy Board Member | 0 companies |